Biocryst Pharmaceuticals Inc
Nasdaq · Healthcare · Biological Products, (No Diagnostic Substances) · Durham, NC
BCRX chart
What traders are saying about $BCRX
Latest postsBiocryst Pharmaceuticals Inc news
- BioCryst Pharmaceuticals, Inc. Estimates – NASDAQ:BCRX
TradingView ·
- TD Cowen maintains USD 30.00 target for BioCryst Pharmaceuticals stock
ad-hoc-news.de ·
- FDA Clears Oral Pellets That Could Be A Game Changer For BioCryst Pharmaceuticals (BCRX)
Simply Wall Street ·
- BioCryst Pharmaceuticals Q3FY26 Results: Earnings call set for Nov 4
scanx.trade ·
- BioCryst to Report Third Quarter 2026 Financial Results on November 4
Yahoo Finance ·
- A live webcast will accompany BioCryst’s results call at 8:30 a.m. ET on Nov. 4.
Stock Titan ·
- BioCryst Pharmaceuticals (BCRX) Gains FDA Nod for New Orladeyo O
GuruFocus ·
- TD Cowen Maintains BioCryst Pharmaceuticals(BCRX.US) With Buy Rating, Maintains Target Price $30
Moomoo ·
- BioCryst Pharmaceuticals wins FDA approval for 150 mg ORLADEYO pellets
Mugglehead Investment Magazine ·
- BioCryst Announces U.S. FDA Approval of ORLADEYO® 150 mg Oral Pellets for Adults and Adolescents with HAE
Yahoo Finance ·
- A daily medicine to prevent attacks from a hereditary swelling disorder now comes as pellets for people 12 and older.
Stock Titan ·
- BioCryst (BCRX) Trades at Just 11x Forward Earnings. Is the Market Pricing In Trouble?
Yahoo Finance ·
Biocryst Pharmaceuticals Inc key financials
| USD | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|
| Revenue | – | – | – | – |
| Net income | $263.9M | -$88.9M | -$226.5M | -$247.1M |
| Diluted EPS | $1.21 | $-0.43 | $-1.18 | $-1.33 |
| Total assets (year end) | $514.2M | $490.4M | $517.0M | $550.0M |
| Cash and equivalents (year end) | $89.7M | $104.7M | $110.6M | $304.8M |
Calendar-year figures as reported to the SEC in XBRL filings.
Recent SEC filings
About Biocryst Pharmaceuticals Inc
- Ticker
- BCRX (Nasdaq)
- Industry
- Biological Products, (No Diagnostic Substances)
- Headquarters
- Durham, NC
- Incorporated in
- DE
- Fiscal year end
- December 31
- SEC CIK
- 882796
Frequently asked questions
What exchange is Biocryst Pharmaceuticals Inc listed on?
Biocryst Pharmaceuticals Inc trades on the Nasdaq under the ticker symbol BCRX.
What industry is Biocryst Pharmaceuticals Inc in?
Biocryst Pharmaceuticals Inc is classified by the SEC under "Biological Products, (No Diagnostic Substances)", part of the Healthcare sector on StockTweeting.
Where is Biocryst Pharmaceuticals Inc headquartered?
Biocryst Pharmaceuticals Inc's business address on file with the SEC is in Durham, NC.
When does Biocryst Pharmaceuticals Inc's fiscal year end?
Biocryst Pharmaceuticals Inc's fiscal year ends on December 31.
How much revenue did Biocryst Pharmaceuticals Inc report?
Biocryst Pharmaceuticals Inc reported $25.2M in revenue for calendar year 2017, according to its SEC filings.